metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Neurological focal signs as a first manifestation of cardiac myxoma
Información de la revista
Vol. 28. Núm. 6.
Páginas 384-385 (julio - agosto 2013)
Vol. 28. Núm. 6.
Páginas 384-385 (julio - agosto 2013)
Letter to the Editor
Acceso a texto completo
Neurological focal signs as a first manifestation of cardiac myxoma
Focalidad neurológica como primera manifestación de un mixoma cardiaco
Visitas
3243
I. González-Suárez
Autor para correspondencia
igonsua@gmail.com

Corresponding author.
, A. Rodríguez-Sanz, A. Tallón-Barranco, E. Diez-Tejedor
Unidad de Ictus, Departamento de Neurología, Hospital Universitario La Paz, UAM, IdiPAZ, Madrid, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo
Dear Editor:

Cerebral infarcts are the third most common cause of death in Spain and the leading cause of physical disability in adults. Twenty-five per cent of all strokes occur in people younger than 65.1,2 Cardiac tumours are a very rare disease with an incidence that ranges from 0.001% to 0.28% in post-mortem studies. Half of such tumours are of myxomatous origin. They are an infrequent cause of cerebral embolism and account for less than 1% of all strokes.3 Although they are rare, they must be considered in the differential diagnosis of all young patients with cerebral ischaemia. We present the case of a patient who experienced acute neurological deficit and prior episodes of transient cerebral ischaemia.

Female patient aged 33 with a personal history of depressive syndrome and chronic anaemia that remained uncorrected after treatment with ionic iron. The patient came to the hospital due to a 2-hour transient episode of diplopia. She reported having had a similar episode previously. Upon arrival at the hospital, the patient presented no neurological symptoms. However, the examination revealed significant purpuric lesions on the thighs and crura, and on the distal parts of the upper limbs. During her stay in the emergency department, doctors performed laboratory tests, an ECG, and a cranial CT, none of which revealed pathological findings. Once the patient was admitted, doctors began the procedure described below for diagnosing stroke in young patients. (a) Haematological analysis, which revealed chronic anaemia disease with an increase in acute-phase reactants; immunology study (ANAs, ANCAs, anti-DNA, anticardiolipin and antiphospholipid, anti-Ro, anti-La, rheumatoid factor, and anti-ACh receptor antibodies) and hypercoagulation study (all results negative); (b) lumbar puncture showing absence of oligoclonal bands and negative Link and Tibbling index; (c) brain MRI showing old ischaemic lesions in cerebellar hemispheres; (d) vascular cerebral study by means of CT angiogram and neurosonology that revealed no significant haemodynamic disorders; (e) transthoracic echocardiogram (TTE) with a subsequent transoesophageal approach (TEE) showing a mass of 11cm2 in the LA that suggested atrial myxoma (Fig. 1); (f) heart MRI confirming the presence of a mass with irregular contours in the LA; and (g) biopsy of the cutaneous lesions, which showed intravascular thrombi consisting of angiomyomatous tissue.

Figure 1.

The images in the first column were taken with TEE; above, 2D image showing 5 cavities and below, 3D image showing full volume. Both images reveal a mass with irregular contours on the LA that enters the LV during diastole. The image in the second column is a cardiac MRI slice showing an intra-atrial mass (arrows).

(0.13MB).

Despite prophylactic treatment with anticoagulants, the patient presented a new episode of cerebral ischaemia during the diagnostic process. The episode was characterised by right-sided paraesthesia that lasted 30minutes before resolving completely. Doctors resected the mass which was of myxomatous origin according to the histological study. Subsequent check-ups performed by the outpatient cardiology unit indicate that the patient has had no clinical or echocardiographic signs of a relapse.

Atrial myxoma is a benign tumour which mainly affects women (2:1) aged between 30 and 60. Although these tumours mainly arise sporadically, 7% of all cases have a familial component. Up to 10% of the cases may be asymptomatic, while the rest may present symptoms through 3 basic mechanisms: (a) mitral valve obstruction with symptoms of dyspnoea, heart failure or sudden death; (b) constitutional symptoms such as fever, arthralgia, or weight loss which may be related to interleukin 6 synthesis by the tumour; and (c) embolic phenomena in peripheral organs.4–6 Neurological symptoms are present in between 26% and 45% of the patients, with cerebral infarct being the most prevalent condition.6–9 Researchers have described completely asymptomatic cases of ischaemic lesions of different sizes and location that were detected by brain MRI.10 Symptoms resulting from tumour infiltration are less common; researchers have described intracranial aneurysms which are secondary to the infiltration of the vascular wall, as well as tumours secondary to the parenchymatous infiltration. Neurological follow-up is therefore advisable, since these complications can occur years after resection of the tumour.7,11

Diagnosis is based on the echocardiogram, which has a diagnostic sensitivity of 100% according to different series.7 The transoesophageal approach is the technique of choice as it provides a better view of the atrium and enables detection of smaller tumours.12 Cardiac MRI may be useful, considering that ultrasound sometimes presents false negatives, underdiagnoses the extension of the tumour, or offers limited information about its type.7 Additional tests, such as a cutaneous biopsy revealing angiomyomatous tissue in the capillary lumen, may help doctors establish a diagnosis.13

In a case of suspected cardiac myxoma, surgical resection should be performed as soon as possible given the high risk of recurring embolic phenomena.4,14,15 When surgery is scheduled, secondary prevention may be a matter of debate. The use of antiplatelet or anticoagulation therapy has been recommended due to the embolic nature of this disease, but there is no consensus regarding the use of these drugs,7 and embolic relapses may occur despite treatment.8

Recurrence of myxoma has been observed in between 2% and 5% of the sporadic cases and in 22% of the familial cases.7,8 Therefore, researchers recommend a yearly echocardiographic study during the first 3 or 4 years,3,5 even if there are no guidelines on this topic.

References
[1]
Estrategia en ictus del Sistema Nacional de Salud.
Ministerio de Sanidad y Política Social, (2009),
[2]
J.M. Ferro, A.R. Massaro, J.L. Mas.
Aetiological diagnosis of ischaemic stroke in young adults.
Lancet Neurol, 9 (2010), pp. 1085-1096
[3]
S.L. Novendstern, S.L. Silliman, R.P. Booth.
Cerebrovascular complications of atrial myxoma.
Hosp Phys, 3 (2001), pp. 39-42
[4]
K.N. Reynen.
Cardiac myxomas.
Engl J Med, 333 (1995), pp. 1610-1617
[5]
F. O’Rourke, N. Dean, M.S. Mouradian, N. Akhtar, A. Shuaib.
Atrial myxoma as a cause of stroke: case report and discussion.
CMAJ, 169 (2003), pp. 1049-1051
[6]
V. Lee, H. Connolly, R.D.J. Brown.
Central nervous system manifestations of cardiac myxoma.
Arch Neurol, 64 (2007), pp. 1115-1120
[7]
E.I. Ekinci, G.A. Donnan.
Neurological manifestations of cardiac myxoma: a review of the literature and report of cases.
Int Med J, 34 (2004), pp. 243-249
[8]
L.E. Knepper, J. Biller, H.P. Adams Jr., A. Bruno.
Neurologic manifestations of atrial myxoma. A 12-year experience and review.
Stroke, 19 (1988), pp. 1435-1440
[9]
E. Hofmann, T. Becker, R. Romberg-Hahnloser, H. Reichmann, M. Warmuth-Metz, M. Nadjmi.
Cranial MRI and CT in patients with left atrial myxoma.
Neuroradiology, 34 (1992), pp. 57-61
[10]
M.B. Altundag, G. Ertas, A.R. Ucer, S. Durmus, H. Abanuz, T. Calikoglu, et al.
Brain metastasis of cardiac myxoma: case report and review of the literature.
J Neuro-Oncol, 75 (2005), pp. 181-184
[11]
F.J. Rodriguez, R.D. Brown, J.P. Mohr, D.G. Piepgras, K. Thielen, R.S. Blume, et al.
Embolic atrial myxoma with neoplastic aneurysm formation and haemorrhage: a diagnostic challenge.
Neuropathol Appl Neurobiol, 32 (2006), pp. 213-216
[12]
A. Mugge, W.G. Daniel, A. Haverich, P.R. Lichtlen.
Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches.
Circulation, 83 (1991), pp. 70-78
[13]
M.J. García-F-Villalta, T. Sanz-Sánchez, M. Aragües, A. Blasco, J. Fraga, A. García-Diez.
Cutaneous embolization of cardiac myxoma.
Br J Dermatol, 147 (2002), pp. 376-382
[14]
M.V.F. Arruda, D.M. Braile, M.R. Joaquim, M.J. Soares, R.H. Alves.
Resection of left ventricular myxoma after embolic stroke.
Rev Bras Cir Cardiovasc, 23 (2008), pp. 578-580
[15]
B.K. Semb.
Surgical considerations in the treatment of cardiac myxoma.
J Thorac Cardiovasc Surg, 87 (1984), pp. 251-259

Please cite this article as: González-Suárez I., et al. Focalidad neurológica como primera manifestación de un mixoma cardiaco. Neurología. 2013;28:384–5

Copyright © 2011. Sociedad Española de Neurología
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos